For the Inventor, By the Inventor

Enter assignee name

Academia Sinica

USPTO Granted Patents = 726

% Expired Patents = 29.9

CIPO Patents = 11

EPO Patents = 111

Forward Citations = 2,584

Loading Chart...

Loading Chart...

1,226 inventors (with patents filed for the assignee):

Chi-Huey Wong (90 out of 173 patents)

Chung-Yi Wu (36 out of 50 patents)

Han-Chung Wu (26 out of 36 patents)

4. Su-May Yu (22 out of 27 patents)

5. Chung-Hsuan Chen (22 out of 24 patents)

6. Jim-Min Fang (20 out of 30 patents)

7. Alice L Yu (18 out of 19 patents)

8. Che Ma (18 out of 18 patents)

9. Lie-Fen Shyur (17 out of 17 patents)

10. Wen-Chin Yang (16 out of 16 patents)

11. Ting-Jen Rachel Cheng (16 out of 16 patents)

12. Pan-Chyr Yang (15 out of 31 patents)

13. Che-Kun James Shen (14 out of 14 patents)

14. Shu-Mei Liang (14 out of 20 patents)

15. Ing-Shouh Hwang (14 out of 14 patents)

Core Competencies:

Recombinant Antibodies

Antiviral Lectins

Therapeutic Nanoparticles

Chimeric Vaccines

Protein Aggregates

Biomarkers

Neurodegenerative Diseases

Cancer Detection

Diabetes Treatment

Immunization Methods

SARS-CoV-2 Spike Protein

Stem Cell Therapy

726 patents: Sort by Forward Citations

1. 12735697 - METHOD FOR SELECTING ANTIBODY FRAGMENTS, RECOMBINANT ANTIBODIES PRODUCED THEREFROM, AND USES THEREOF (2026-09-15),

2. 12734172 - Method and composition for treating pain (2026-09-15),

3. 12710430 - LAMA2, PLXDC2 AND MLL4 AS NOVEL BIOMARKERS FOR PREDIABETES AND DIABETES (2026-08-18),

4. 12702716 - MONOCYTE-SPECIFIC APTAMERS AND USES THEREOF FOR DELIVERING THERAPEUTIC AGENTS TO HEART (2026-08-11),

5. 12693513 - Microscope-based system and method for image-guided microscopic illumination (2026-07-28),

6. 12693512 - Microscope-based system and method for image-guided microscopic illumination (2026-07-28),

7. 12667832 - Catalysts and their uses in one-pot diastereoselective synthesis of remdesivir (2026-06-30),

8. 12662711 - NOVEL ENTEROVIRUS 71 MUTATIONS ASSOCIATED WITH DISEASE SEVERITY (2026-06-23),

9. 12661378 - METHODS FOR ENHANCING LIFESPAN AND/OR TREATING CELLULAR PROLIFERATIVE DISORDERS BY TRANSPLANTATION (2026-06-23),

10. 12645061 - Microscope-based system and method for image-guided microscopic illumination (2026-06-02),

11. 12617826 - CLEC2 FUSION PROTEIN AND USES THEREOF (2026-05-05),

12. 12605353 - PDIA4 inhibitors and use thereof for inhibiting β-cell pathogenesis and treating diabetes (2026-04-21),

13. 12599644 - TREATMENT OF CORONAVIRUS INFECTION WITH FLT3 RECEPTOR INTERACTING LECTIN (FRIL) (2026-04-14),

14. 12590130 - BIPARTITE MOLECULES AND USES THEREOF IN TREATING DISEASES ASSOCIATED WITH ABNORMAL PROTEIN AGGREGATES (2026-03-31),

15. 12584917 - RECOMBINANT ANTIBODIES, KITS COMPRISING THE SAME, AND USES THEREOF (2026-03-24),

Company Overview

Academia Sinica, located in Taipei, Taiwan, is a premier research institution dedicated to advancing knowledge in the field of biotechnology. The organization specializes in the development of innovative solutions such as recombinant antibodies, antiviral lectins, and therapeutic nanoparticles. Its research encompasses critical areas including chimeric vaccines, protein aggregates, biomarkers, and the study of neurodegenerative diseases and cancer detection, contributing significantly to both scientific understanding and potential therapeutic applications.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

726 Patents

#8 in Taipei

#45 in Taiwan

#1,369 in the World

Academia Sinica

Forward Citations = 2,584

1,226 inventors:

Chi-Huey Wong (90 out of 173 patents)

Chung-Yi Wu (36 out of 50 patents)

Han-Chung Wu (26 out of 36 patents)

4. Su-May Yu (22 out of 27 patents)

5. Chung-Hsuan Chen (22 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Academia Sinica. Retrieved from https://idiyas.com/company/academia-sinica

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…